The patient monitoring devices market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period. The growth of this market is mainly driven by increasing number of hospitals in key markets, increasing adoption of wearable and wireless patient monitoring devices for home care, and increasing awareness of monitoring essential parameters for the treatment and diagnosis of chronic diseases.

Browse in-depth TOC on "Patient Monitoring Devices Market"

328 – Tables

39 – Figures

354 – Pages

Download PDF Brochure @

Key Market Players

Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Drägerwerk AG Co. KGaA (Germany), Edwards Lifesciences Corporation (US), OMRON Corporation (Japan), Masimo Corporation (US), Compumedics Limited (Australia), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden Corporation (Japan), Natus Medical (US), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Getinge AB (Sweden), Boston Scientific Corporation (US), Dexcom, Inc. (US), Nonin (US), BIOTRONIK (Germany), SCHILLER (Switzerland), and BioTelemetry, Inc. (US)

Growth Strategies Adopted:

The competitive landscape includes the analysis of the key growth strategies adopted by major players between 2017–2020 to expand their global presence and increase their market shares in the patient monitoring devices market. The key growth strategies adopted by the top players in the market include product launches and approvals, agreements, expansions, and acquisitions. Product approvals and launches were the most widely adopted growth strategies by market players in the last three years to garner a larger share of the market.

Medtronic plc (US) has a wide range of product offerings in the patient monitoring devices market, including neuromonitoring, respiratory monitoring devices, cardiac monitoring devices, and blood glucose monitoring products. The company’s flagship product─BIS brain monitoring system–is among the most widely used systems in the patient monitoring devices market.

GE Healthcare (US) is a leader in the global patient monitoring devices market. GE Healthcare is a developer of innovative solutions for patient monitoring devices in fields such as multi-parameter monitoring devices, cardiac monitoring devices, and fetal and neonatal monitoring devices.

Request for Sample Pages @

The ECG devices sub segment of cardiac monitoring devices products to hold major market share by 2025

The patient monitoring device market is segmented into blood glucose monitoring systems, cardiac monitoring devices, multiparameter monitoring devices, respiratory monitoring devices, temperature monitoring devices, hemodynamic/pressure monitoring devices, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices and other patient monitoring devices.

North America is expected to dominate the global patient monitoring market

North America, comprising the US and Canada, accounted for the largest share of the patient monitoring devices market. Increasing number of clinical trials validating patient monitoring devices and a growing number of approvals for patient monitoring.

Get Special Pricing on Bundle Reports @